Thompson Tamar insider trades
Thompson Tamar has filed 12 Form 4s with the SEC that we hold, for Catalyst Pharmaceuticals, INC. (CPRX) (Director) and RNAM (Director). Across all of them we count 0 purchases worth $0 and 1 sale worth $1.3M reported on Form 4. None of these purchases or sales is dated in the last 12 months. The largest single trade was a sale of 30,000 shares of RNA worth $1.3M, dated 2024-10-07. The first filing on our record is dated 2022-06-17 and the latest 2026-07-17.
Catalyst Pharmaceuticals, INC. (CPRX)
No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.
RNAM
| Trade date | Code | Shares | Value as filed | Filed |
|---|---|---|---|---|
| 2024-10-07 | S, sale reported on Form 4 | 30,000 | $1.3M | 2024-10-09 |
Counted from the Form 4 filings this reporting owner (SEC CIK 1839248) filed on EDGAR. Values are the transaction values as filed. See every filing on EDGAR, or browse insider buying and today's insider purchases.
Source: U.S. Securities and Exchange Commission (EDGAR) and other official
government data · Updated 2026-10-12 ·
For informational purposes only, not investment advice.
Privacy · Terms